patent/WO-2006067332-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19aa92643b05af50b5965f5d165d60f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76f9449c2a4d1429f17eb5b0311eada5
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
filingDate	2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f707f03147ad217a7246771cef4037
publicationDate	2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2006067332-A1
titleOfInvention	Use of botulinum toxin for prolonged local desensitization
abstract	The invention concerns the use or a fragment of botulinum toxin having said toxin activity for preparing a medicine for reversibly desensitizing an area of the skin, said skin area being designed to receive injections. Said injections can be related, for example, to repeated delivery of insulin, growth hormones or other medicines in injectable form.
priorityDate	2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0178760-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5589192-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004006954-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135919923 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420612 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414555 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71349 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688096 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980

Total number of triples: 23.